The State of Biotechnology APIs

About this report

The largest industry population this research has measured and the smallest programmable core inside it: 1,108 organisations, 20 in the upper three bands, and not one exemplar — the only section of nine with none. 889 of the first thousand hold no machine-readable contract of any kind. This is a science industry with a software layer, not a software industry, and the report is written to say which is which.

20 companies. Kin Score median 48.9, Agent Readiness median 38.3. 0 reach the Exemplar band; 1009 sit in Emerging or Minimal. Every one of them is named and ranked in the report — if you work in this market, you are in the table, and so is everyone you compete with.

An industry that built three workflow languages and published zero workflow contracts. Biotechnology solved sequencing, orchestration and reproducibility for compute pipelines over twenty years, and never once pointed that machinery at its own interfaces.

What's inside

1. Executive summary
2. The state of the market
3. The resource taxonomy — what this market actually exposes
4. The vocabulary, as functions
5. Glossary
6. The composite Kin Score — and why it is the foundation
7. Agent readiness — a separate instrument
8. The blueprint — what the leaders satisfy and nobody else does
9. Who this market depends on — and whether they publish
10. The standards layer
11. The regulatory layer
12. Artifacts for the agentic turn — and the workflow gap
13. Security, authentication and scopes
14. Provider-by-provider intelligence, and the whole market ranked
15. The investable thesis
16. Coverage and method
17. The climb — what moves a company here
18. Where this is going

What you get for $500.00